---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-103498"
form_type: "8-K"
ticker: "ATNM"
cik: "0001388320"
company_name: "Actinium Pharmaceuticals, Inc."
filed_at: "2024-11-27T23:59:59+00:00"
generated_at: "2026-05-29T13:44:54.766999+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Actinium re-elects Class II directors Seth and Chell, ratifies Marcum as auditor at 2024 annual meeting

## Summary
- Sandesh Seth and Jeffrey W. Chell re-elected as Class II directors for three-year terms expiring at 2027 annual meeting.
- Marcum LLP ratified as independent registered public accounting firm for fiscal year ending Dec 31, 2024.
- Approximately 63.2% of outstanding shares (19.7M of 31.2M) were represented at the meeting.

## SEC filing metadata
- accession: 0001213900-24-103498
- form_type: 8-K
- ticker: ATNM
- cik: 0001388320
- company_name: Actinium Pharmaceuticals, Inc.
- filed_at: 2024-11-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1388320/000121390024103498/0001213900-24-103498-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1388320/000121390024103498/ea0222950-8k_actinium.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-103498
- JSON: https://secwatch.observer/filing/0001213900-24-103498.json
- Plain text: https://secwatch.observer/filing/0001213900-24-103498.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.